MSAC knocks back Gilead CAR T
By Megan Brodie 2 years ago | In Cell and gene therapies, Reimbursement- 2 years ago
30 October 2024 The Medical Services Advisory Committee (MSAC) has rejected Gilead’s first CAR T-cell…
This is subscriber-only content. Please login to continue reading.